title: Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice.
abstract: Isotopic techniques were used to test the hypothesis that exercise and nitric oxide synthase (NOS) inhibition have distinct effects on tissue-specific fatty acid and glucose uptakes in a conscious, chronically catheterized mouse model. Uptakes were measured using the radioactive tracers (125)I-labeled beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) and deoxy-[2-(3)H]glucose (DG) during treadmill exercise with and without inhibition of NOS. [(125)I]BMIPP uptake at rest differed substantially among tissues with the highest levels in heart. With exercise, [(125)I]BMIPP uptake increased in both heart and skeletal muscles. In sedentary mice, NOS inhibition induced by nitro-L-arginine methyl ester (L-NAME) feeding increased heart and soleus [(125)I]BMIPP uptake. In contrast, exercise, but not L-NAME feeding, resulted in increased heart and skeletal muscle [2-(3)H]DG uptake. Significant interactions were not observed in the effects of combined exercise and L-NAME feeding on [(125)I]BMIPP and [2-(3)H]DG uptakes. In the conscious mouse, exercise and NOS inhibition produce distinct patterns of tissue-specific fatty acid and glucose uptake; NOS is not required for important components of exercise-associated metabolic signaling, or other mechanisms compensate for the absence of this regulatory mechanism.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. jeff.rottman@mcmail.vanderbilt.edu
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Rottman
authors.forename: Deanna
authors.initials: D
authors.lastname: Bracy
authors.forename: Carlo
authors.initials: C
authors.lastname: Malabanan
authors.forename: Zou
authors.initials: Z
authors.lastname: Yue
authors.forename: Jeff
authors.initials: J
authors.lastname: Clanton
authors.forename: David H
authors.initials: DH
authors.lastname: Wasserman
mesh_terms: D000284:Administration, Oral; D000818:Animals; D003847:Deoxyglucose / Q000493:pharmacokinetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism* / Q000493:pharmacokinetics; D005947:Glucose / Q000493:pharmacokinetics*; D007457:Iodine Radioisotopes; D007462:Iodobenzenes / Q000493:pharmacokinetics; D051379:Mice; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009928:Organ Specificity / Q000187:drug effects / Q000502:physiology*; D005082:Physical Exertion / Q000502:physiology*; D014316:Tritium
chemical_list: D004791:Enzyme Inhibitors; D005227:Fatty Acids; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; C049338:iodofiltic acid; D014316:Tritium; D003847:Deoxyglucose; D019001:Nitric Oxide Synthase; D005947:Glucose; D019331:NG-Nitroarginine Methyl Ester